RNGTT — patent landscape

Top predicted compounds (top 20 by supporting neighbours, then confidence)

Compound	Confidence	Supporting neighbours
Molibresib (SCHEMBL1872390)	1.00	1/20
Molibresib (SCHEMBL12671490)	1.00	1/20
Molibresib (SCHEMBL12966358)	1.00	1/20
SCHEMBL9998851	0.91	1/20
SCHEMBL14756282	0.88	1/20
SCHEMBL15980874	0.88	1/20
SCHEMBL12966165	0.87	1/20
SCHEMBL14756215	0.87	1/20
SCHEMBL14756339	0.87	1/20
SCHEMBL15980861	0.87	1/20
SCHEMBL9998825	0.86	1/20
SCHEMBL15980893	0.86	1/20
SCHEMBL15980803	0.86	1/20
SCHEMBL1874116	0.85	1/20
SCHEMBL12671221	0.85	1/20
SCHEMBL14756021	0.85	1/20
SCHEMBL14756240	0.85	1/20
SCHEMBL14756287	0.85	1/20
SCHEMBL14756335	0.85	1/20
SCHEMBL14756409	0.85	1/20

Clinical trials — most relevant to RNGTT by text similarity (a relevance ranking, not an exhaustive list)

Trial	Phase	Status
Effects of Exercise Training on Systemic Inflammation an Muscle Repair According to the Obstructive Chronic Pulmonary Disease (COPD) Phenotype	PHASE4	UNKNOWN
Clinical Study of EBV-LMP1 Targeted DNAzyme to Treat Nasopharyngeal Carcinoma	PHASE1/PHASE2	COMPLETED
A Phase 1/2 Study of STP938 (Dencatistat) for Adult Subjects With Relapsed/Refractory B-Cell and T-Cell Lymphomas	PHASE1/PHASE2	RECRUITING
Safety and Efficacy Study of Small Interfering RNA Molecule (Cand5) to Treat Diabetic Macular Edema	PHASE2	COMPLETED
Combination Chemotherapy in Treating Patients With Previously Untreated Stage II or Stage III Esophageal Cancer That Can Be Removed By Surgery	PHASE2	COMPLETED
Liver Resection and Floxuridine Plus Fluorouracil and Leucovorin in Treating Patients With Liver Metastases From Colorectal Cancer	PHASE2	COMPLETED
MiRNA223 and HMGB1 as Apredictos for Drug Resistant Epilepsy	nan	UNKNOWN
Pilot Study on Molecular Quantitation and Sequencing of Endometrial Cytokines Gene Expression and Their Effect on the Outcome of In-vitro Fertilization (IVF) Cycle	nan	UNKNOWN
Methylation of DNA in Children and Adolescents With Type 1 Diabetes Mellitus (METHYLDIAB)	nan	COMPLETED
The Value of circRNAs (hsa_circ_0004001) in Early Diagnosis of HCC	nan	UNKNOWN
Using the Epitranscriptome to Diagnose and Treat Gliomas	nan	RECRUITING
Determination of the Effectiveness of Oral Chlorine Dioxide in the Treatment of COVID 19	nan	UNKNOWN
Investigation of the Genetic and Environmental Causes of Autism: a Multi-Center Study	nan	NOT_YET_RECRUITING
The Molecular Pathogenesis Study of Cataract	nan	UNKNOWN
Effect of DNMT SNPs on DNA Methylation in Primary ITP	nan	UNKNOWN
Role of Multiplex PCR in CAP	nan	UNKNOWN
Role of SF3B1 Mutation in Assessment of Acute and Chronic Lymphatic Leukemia	nan	NOT_YET_RECRUITING
RNA Sequencing in the Framingham Heart Study Third Generation Cohort Exam 2	nan	COMPLETED
Efficacy of a Multiplex BangasureTM RT-PCR Kit for the Detection of COVID-19	nan	COMPLETED
Epitranscriptomic Blood Biomarkers for Coronary Artery Disease - A Prospective Cohort Study (IHD-EPITRAN)	nan	UNKNOWN
Study of Specimens From Young Patients With Neuroblastoma	nan	COMPLETED
Markers in Acute Pancreatitis-1	nan	COMPLETED
The Effect of Ca(OH)2 in Apical Periodontitis	nan	COMPLETED
miR-155 Expression in Episodic and Chronic Migraine	nan	UNKNOWN
The Role of Circulating CircRNAs and MicroRNAs in Acute Lung Injury	nan	UNKNOWN
Effect of Branched Chain Amino Acids on Muscle	nan	COMPLETED
Timisnar - Biomarkers Substudy (Timisnar-mirna)	nan	UNKNOWN
LINC00511/miR-185-3p Axis and miR-301a-3p Markers for Breast Cancer Diagnosis	nan	COMPLETED
Inhibition of SENP1 for the Suppression of OS Growth and Metastasis	nan	UNKNOWN
Search for Bovine miRNA Transference to Humans	nan	COMPLETED

Related proteins — ESM-2 sequence neighbours (a RNGTT binder may also engage these)

Protein	Name	Similarity
O55236	—	1.000	O55236 →
Q6NY98	—	0.995	Q6NY98 →
A0FKG7	—	0.971	A0FKG7 →
P97789	—	0.970	P97789 →
Q8IZH2	—	0.970	Q8IZH2 →
Q5R8R4	—	0.968	Q5R8R4 →
Q9Y6W3	—	0.968	Q9Y6W3 →
Q4V7N2	—	0.966	Q4V7N2 →
Q9QW07	—	0.966	Q9QW07 →
Q64514	—	0.966	Q64514 →
UBA2	SUMO-activating enzyme subunit 2	0.966	landscape →
Q5ZKY2	—	0.966	Q5ZKY2 →
Q9R1S8	—	0.965	Q9R1S8 →
MAP4K5	Mitogen-activated protein kinase kinase kinase kinase 5	0.965	landscape →
Q6NYU2	—	0.965	Q6NYU2 →
Q9Z1F9	—	0.964	Q9Z1F9 →
O08586	—	0.964	O08586 →
ERCC4	DNA repair endonuclease XPF (EC 3.1.-.-) (DNA	0.964	landscape →
Q9LL84	—	0.964	Q9LL84 →
TPP2	Tripeptidyl-peptidase 2	0.963	landscape →
Q5XGS8	—	0.963	Q5XGS8 →
Q8IWV8	—	0.963	Q8IWV8 →
PTEN	Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN	0.963	landscape →
Q8BPM2	—	0.963	Q8BPM2 →
O55091	—	0.962	O55091 →
Q5RGJ5	—	0.962	Q5RGJ5 →
Q8QFR2	—	0.962	Q8QFR2 →
Q1HFZ0	—	0.962	Q1HFZ0 →
O54857	—	0.962	O54857 →
PLCB1	1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1	0.962	landscape →